Shares of beer powerhouse Anheuser-Busch InBev (NYSE:BUD)
fell 12% in the afternoon session after the company reported second-quarter results that fell short of market expectations, driven by weak demand in key international markets. The world's largest brewer announced that its total sales volume decreased by 1.9%, with beer volume specifically dropping 2.2%, a larger decline than analysts anticipated. The company’s revenue landed at $15.0 billion, which missed consensus estimates. The performance stemmed largely from significant sales drops in key international markets. In China, revenue fell 6% as volumes decreased by over 7%, while in Brazil, volumes plunged by more than 6.5%. The disappointing report intensified investor concerns about shifting consumer preferences away from traditional beer products.
Beer powerhouse Anheuser-Busch InBev (NYSE:BUD) fell short of the market’s revenue expectations in Q2 CY2025, with sales falling 2.1% year on year to $15 billion. Its GAAP profit of $0.98 per share was in line with analysts’ consensus estimates.
Even if a company is profitable, it doesn’t always mean it’s a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. But recently, the industry has failed to do its job as it shed 10.8% over the past six months. This performance was especially disheartening since the S&P 500 held its ground.
These three stocks have received a rare double upgrade from analysts since their most recent earnings reports; fortunately investors still have time to catch up
Beer powerhouse Anheuser-Busch InBev (NYSE:BUD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.3% year on year to $13.63 billion.
Large-cap stocks usually command their industries because they have the scale to drive market trends.
The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
US companies are reshoring manufacturing operations & investing billions in the country, led by Apple & Nvidia for tech, J&J & Eli Lilly for healthcare, Anheuser-Busch for beer, & Cra-Z-Art for toys. Detroit & beyond are benefiting from this trend.
A company with profits isn’t always a great investment.
Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the beverages, alcohol, and tobacco industry, including Anheuser-Busch (NYSE:BUD) and its peers.
